FDA-Approved MedicationUpdated November 2026

Mounjaro Guide

Mounjaro is the brand-name formulation of tirzepatide FDA-approved for type 2 diabetes in adults and children 10 and older, and to reduce major cardiovascular events in high-risk adults with type 2 diabetes, manufactured by Eli Lilly. It is prescribed weekly by injection and has become extremely popular off-label for weight loss given its superior efficacy data. The weight-management indication for tirzepatide belongs to its sister brand, Zepbound.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed

At a Glance

Generic NameTirzepatide
Brand NamesMounjaro
FDA StatusFDA-approved for type 2 diabetes in adults (May 2022), extended to pediatric patients aged 10+ (December 2025), and approved to reduce major adverse cardiovascular events in high-risk adults with type 2 diabetes (August 2026). Off-label use for weight loss is common; the weight management indication is covered by Zepbound (FDA-approved November 2023).[1]
Approval DateMay 13, 2022[1]

How Mounjaro Works

Mounjaro's tirzepatide activates both GIP and GLP-1 receptors — making it a "dual agonist" or "twincretin." For diabetes, this dual action powerfully lowers blood sugar by increasing insulin secretion and reducing glucagon. The same pathways simultaneously reduce appetite, slow gastric emptying, and appear to act directly on fat cells — producing the highest weight loss rates of any approved medication.[2][3]

Dosing Schedule

Mounjaro uses a gradual dose escalation to minimize side effects. Always follow your prescriber's guidance and the current FDA label[1].

Weeks 1–42.5mg/week
Weeks 5–85mg/week
Weeks 9–127.5mg/week
Weeks 13–1610mg/week
Weeks 17–2012.5mg/week
Week 21+15mg/week (adult max; 10mg max in pediatric patients 10+)

Side Effects

Common: nausea (12–18%), diarrhea (12–17%), vomiting (5–9%), constipation (6–7%), decreased appetite, abdominal pain, injection site reactions. Side effects typically improve after the first 4–8 weeks. Serious (rare): pancreatitis, gallbladder disease, hypoglycemia, acute kidney injury.[1][2]

This is not a complete list. Consult your healthcare provider or prescriber for full safety information. The complete adverse reaction profile is published in the current FDA prescribing information[1].

Clinical Trial Results

In the SURPASS-2 trial, Mounjaro (tirzepatide 15mg) reduced HbA1c by 2.46 percentage points and produced 12.4 lbs more weight loss than semaglutide 1mg. Sub-analyses showed 41% of participants achieved an HbA1c below 5.7% — essentially normal blood sugar levels.[2]

Source: Published clinical trial data (STEP / SURMOUNT trial series) — see the Sources panel below for full citations.

Where to Get Mounjaro

These telehealth providers offer access to tirzepatide with online consultations and home delivery. Before you book a consult, our guide to getting Mounjaro online walks through eligibility, the prescriber visit, and what legitimate pharmacy fulfillment looks like.

8.0/ 10
Partner

Sesame Care

Best for: Brand-name GLP-1s at cash prices, no compounding

★★★★☆4/5

Editorial score · methodology

$149/mosemaglutide
see plan details
BrandSemaglutideTirzepatideOrforglipron
Get StartedRead full Sesame Care review →
7.6/ 10
Partner

Maximus

Best for: men seeking compounded tirzepatide alongside testosterone optimization

★★★★☆3.8/5

Editorial score · methodology

$100/mosemaglutide
microdose plan
$100/motirzepatide
12-month plan rate
CompoundedSemaglutideTirzepatideOrforglipronSermorelinFDA Warning
Get StartedRead full Maximus review →
7.6/ 10
Partner

SkinnyRx

Best for: compounded semaglutide or tirzepatide with the consult and free overnight shipping in one price

★★★★☆3.8/5

Editorial score · methodology

$99/mosemaglutide
intro price
$299/motirzepatide
after intro offer
CompoundedSemaglutideTirzepatideOrforglipronSermorelinFDA Warning
Get StartedRead full SkinnyRx review →
6.9/ 10
Partner

DudeMeds

Best for: men seeking no-fee compounded or brand-name GLP-1 injections

★★★★☆3.5/5

Editorial score · methodology

$175/mosemaglutide
6-month plan rate
$233/motirzepatide
prepaid plan rate
CompoundedSemaglutideTirzepatideNAD+
Get StartedRead full DudeMeds review →
8.4/ 10

Vytora Health

Best for: compounded or brand-name GLP-1 with named pharmacy partners, 50 states

★★★★☆4.2/5

Editorial score · methodology

$179/mosemaglutide
$249/motirzepatide
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified
Get StartedRead full Vytora Health review →
8.1/ 10

Pallas Health

Best for: the most complete public disclosure of pharmacies and prescribing physicians we have found

★★★★☆4.1/5

Editorial score · methodology

$199/4 wkssemaglutide
billed per 4 weeks
$299/4 wkstirzepatide
billed per 4 weeks
CompoundedSemaglutideTirzepatideOrforglipronNAD+LegitScript Verified
Get StartedRead full Pallas Health review →

Each provider's lowest ongoing monthly cash price for Mounjaro, sorted cheapest first (no copays, membership fees or intro offers). Both compounded and brand-name prescriptions are generally FSA/HSA eligible under IRS Publication 502[6]. Prices may vary based on dose.

ProviderFrom (ongoing)
Sesame Care$499/mostarting doseVisit
Vital Edge$835/moVisit
Maximus$1,250/mostarting doseVisit
WePeptideRx$1,250/moper 4 weeksVisit
Bon Health$1,269/mo+ added feeVisit
Effecty$1,300/mosee plan detailsVisit
Pallas Health$1,349/mosee plan detailsVisit
DudeMeds$1,350/mo3-month plan rateVisit
Vytora Health$1,399/moVisit
SkinnyRx$1,400/mosee plan detailsVisit
Corsica Health$1,499/mosee plan detailsVisit
Layla$1,499/moafter intro offerVisit
myRocky$1,509/moVisit
Hers$1,899/mo+ required membershipVisit
Hims$1,899/mo+ required membershipVisit

Short-form verdict pages comparing Mounjaro to other GLP-1 options with trial-anchored data, FDA-label dosing, and current manufacturer pricing.

See all drug-vs-drug verdicts, or compare every weight loss medication we cover.

Real patient questions about Mounjaro pulled from named subreddits and answered with peer-reviewed trial data.

Scannable cheat sheets for dose schedules, missed-dose rules, and red-flag side effects — every number verified against the DailyMed FDA label.

Curated lists of the highest-impact peer-reviewed studies on Mounjaro and related GLP-1 drugs. Every PMID is checked against its PubMed record.

Deep-dive articles from our research desk with primary-source trial data, FDA label verification, and editorial analysis.

Best Compounding Pharmacy for Tirzepatide? How to Choose a Legit One (2026)
There's no single best compounding pharmacy for tirzepatide — there's a checklist. 503A vs 503B, PCAB accreditation, state licensure, NABP/LegitScript, and a real prescriber. Plus the 2026 legal reality and our vetted providers.
9 min read6 citations
Switching From Semaglutide to Tirzepatide: Washout, Dose & What to Expect (2026)
Switching from semaglutide to tirzepatide: the short 3-7 day timing gap, why you restart at 2.5 mg (no dose-matching, no conversion chart), and what to expect. Prescriber-led.
9 min read6 citations
Mounjaro and Acid Reflux: Heartburn, GERD & How to Manage It (2026)
Is acid reflux a Mounjaro side effect? GERD, dyspepsia, and eructation are labeled tirzepatide reactions because it slows gastric emptying. Why heartburn and the 'Mounjaro burps' happen, how to manage them, the red flags, and why long-term weight loss usually improves reflux.
9 min read5 citations
Zepbound & Mounjaro (Tirzepatide) Results Timeline: What to Expect Week by Week & Month by Month (2026)
What to expect on Zepbound and Mounjaro (tirzepatide) week by week and month by month. SURMOUNT-1 averaged ~15.0% / ~19.5% / ~20.9% body-weight loss at 5/10/15 mg by week 72 — a trial average, not a guarantee. An honest, prescriber-directed 2026 timeline.
11 min read6 citations
Does Inositol Help With Weight Loss in PCOS? Honest Evidence Review
Inositol's strongest evidence is for PCOS-related insulin resistance + ovulation (1-3 kg weight loss + restored cycles). For non-PCOS adults, inositol produces minimal weight effects.
19 min read15 citations
Spironolactone with GLP-1: Potassium, PCOS, and Combined Use Evidence
No GLP-1 label lists an interaction with spironolactone, but the potassium concern is real: GLP-1 GI side effects cause dehydration, which lowers kidney function and lets potassium build up on top of spironolactone's own effect. Practical monitoring for women with PCOS.
18 min read12 citations

Frequently Asked Questions

FDA-approved for type 2 diabetes in adults (May 2022), extended to pediatric patients aged 10+ (December 2025), and approved to reduce major adverse cardiovascular events in high-risk adults with type 2 diabetes (August 2026). Off-label use for weight loss is common; the weight management indication is covered by Zepbound (FDA-approved November 2023).
Among the 15 providers in the cost comparison table above, Mounjaro's lowest ongoing monthly cash price is $499 and the highest is $1,899, depending on provider, form and dose. These are medication prices only — copays, membership fees and intro offers are excluded. Always check for manufacturer savings programs.
Common: nausea (12–18%), diarrhea (12–17%), vomiting (5–9%), constipation (6–7%), decreased appetite, abdominal pain, injection site reactions. Side effects typically improve after the first 4–8 weeks. Serious (rare): pancreatitis, gallbladder disease, hypoglycemia, acute kidney injury.
Mounjaro requires a prescription from a licensed healthcare provider. You can get it through your primary care doctor, endocrinologist, or a telehealth platform. The telehealth providers listed above prescribe it online.
Sources & methodology (as of November 2026)
  1. 1.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  2. 2.SURPASS-2 Trial — Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (Frías JP et al.)— New England Journal of Medicine.PMID: 34170647.
  3. 3.ADA — Standards of Care in Diabetes (2025)— American Diabetes Association.
  4. 4.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  5. 5.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  6. 6.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.